1. Руководство по косметологии / под ред. А.А.Кубанова, Н.Е. Мантуровой, Ю.А. Галлямовой. М.: АНО Издательский Дом «Научное обозрение», 2020. 728
2. Новая косметология. Основы современной косметологии. Е. Эрнандес, А. Марголина. - М.: Издательский дом «Косметика и медицина», 2017. - 440
3. Атлас косметической дерматологии / перевод с английского под редакцией профессора доктора медицинских наук Н. Н. Потекаева. М. Р. Аврам, С. Цзао, З. Танноус, М. М. Аврам. - М. Издательство Бинном, 2013. - 295
4. Косметология: клиническое руководство / О. М. Бурылина, А. В. Карпова. - М.: ГЭОТАР-Медиа, 2018. - 744
5. Федотов Валерий Павлович Расстройства пигментации кожи (дисхромии) // ДВКС. 2014. №. URL: https://cyberleninka.ru/article/n/rasstroystva-pigmentatsii-kozhi-dishromii
6. Л.А. Болотная, И.М. Сербина, Л.И. Бей. НАРУШЕНИЯ ПИГМЕНТАЦИИ КОЖИ И ИХ КОРРЕКЦИЯ В ДЕРМАТОКОСМЕТОЛОГИЧЕСКОЙ ПРАКТИКЕ. Косметология N3 Вересень, 2003. zУДК 616.5003.6.05085
7. Callender V.D., St Surin-Lord S., Davis E.C., et al. Postinflammatory hyperpigmentation: etiologic and therapeutic considerations. Am J Clin Dermatol. 2011 Apr 1;12(2):87-99. doi: 10.2165/11536930-000000000-00000. PMID: 21348540.
8. Clinical cases in Dermatology / Clinical cases in disorders of melanocytes / Sunil Kothiwala, Anup Kumar Tiwary, Piyush Kumar. Series editor: Robert A. Norman. Tampa, FL, USA. - Springer Nature Switzerland AG, 2020 - 207
9. Lawrence E., Al Aboud K.M. Postinflammatory Hyperpigmentation. 2021 Oct 9. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan . PMID: 32644576.
10. Chaowattanapanit S., Silpa-Archa N., Kohli I. et al. Postinflammatory hyperpigmentation: A comprehensive overview: Treatment options and prevention. J Am Acad Dermatol. 2017 Oct;77(4):607-621. doi: 10.1016/j.jaad.2017.01.036. PMID: 28917452.
11. Nipshagen M.D., Velthuis P.J., Mosmuller D.G.M. Periorbital postinflammatory hyperpigmentation after plasma exeresis. Dermatol Ther. 2020 May;33(3):e13404. doi: 10.1111/dth.13404. Epub 2020 Apr 29. PMID: 32279389; PMCID: PMC7317400
12. Plensdorf S, Livieratos M., Dada N. Pigmentation Disorders: Diagnosis and Management. Am Fam Physician. 2017 Dec 15;96(12):797-804. PMID: 29431372.
13. Sofen B., Prado G., Emer J. Melasma and Post Inflammatory Hyperpigmentation: Management Update and Expert Opinion. Skin Therapy Lett. 2016 Jan;21(1):1-7. PMID: 27224897.
14. Davis E.C., Callender V.D. Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color. J Clin Aesthet Dermatol. 2010 Jul;3(7):20-31. PMID: 20725554; PMCID: PMC2921758.
15. Kaufman B.P., Aman T., Alexis A.F. Postinflammatory Hyperpigmentation: Epidemiology, Clinical Presentation, Pathogenesis and Treatment. Am J Clin Dermatol. 2018 Aug;19(4):489-503. doi: 10.1007/s40257-017-0333-6. PMID: 29222629.
16. Silpa-Archa N., Kohli I., Chaowattanapanit S. et al. Postinflammatory hyperpigmentation: A comprehensive overview: Epidemiology, pathogenesis, clinical presentation, and noninvasive assessment technique. J Am Acad Dermatol. 2017 Oct;77(4):591-605. doi: 10.1016/j.jaad.2017.01.035. PMID: 28917451.
17. Zubair R., Lyons A.B., Vellaichamy G. What's New in Pigmentary Disorders. Dermatol Clin. 2019 Apr;37(2):175-181. doi: 10.1016/j.det.2018.12.008. Epub 2019 Feb 16. PMID: 30850040.
18. Taylor S., Grimes P., Lim J. et al. Postinflammatory hyperpigmentation. J Cutan Med Surg. 2009 Jul-Aug;13(4):183-91. doi: 10.2310/7750.2009.08077. PMID: 19706225.
19. Rossi A.M., Perez M.I. Treatment of hyperpigmentation. Facial Plast Surg Clin North Am. 2011 May;19(2):313-24. doi: 10.1016/j.fsc.2011.05.010. PMID: 21763992.
20. Passeron T., Genedy R., Salah L. et al. Laser treatment of hyperpigmented lesions: position statement of the European Society of Laser in Dermatology. J Eur Acad Dermatol Venereol. 2019 Jun;33(6):987-1005. doi: 10.1111/jdv.15497. Epub 2019 Mar 14. PMID: 30873649.
21. Isedeh P., Kohli I., Al-Jamal M. et al. An in vivo model for postinflammatory hyperpigmentation: an analysis of histological, spectroscopic, colorimetric and clinical traits. Br J Dermatol. 2016 Apr;174(4):862-8. doi: 10.1111/bjd.14184. Epub 2015 Dec 13. PMID: 26663029.
22. Epstein JH. Postinflammatory hyperpigmentation. Clin Dermatol. 1989 Apr-Jun;7(2):55-65. doi: 10.1016/0738-081x(89)90057-6. PMID: 2667741.
23. Lacz NL, Vafaie J, Kihiczak NI, Schwartz RA. Postinflammatory hyperpigmentation: a common but troubling condition. Int J Dermatol. 2004;43(5):362 5
24. Hasan AT, Eaglstein W, Pardo RJ. Solar-induced postinflammatory hyperpigmentation after laser hair removal. Dermatol Surg. 1999 Feb;25(2):113-5. doi: 10.1046/j.1524-4725.1999.08108.x. PMID: 10037515.
25. Savory SA, Agim NG, Mao R, et al. Reliability assessment and validation of the postacne hyperpigmentation index (PAHPI), a new instrument to measure postinflammatory hyperpigmenta- tion from acne vulgaris. J Am Acad Dermatol. 2014;70:108-114.
26. Pandya AG, Guevara IL. Disorders of hyperpigmentation. Dermatol Clin. 2000 Jan;18(1):91-8, ix. doi: 10.1016/s0733-8635(05)70150-9. PMID: 10626115.
27. Ruiz-Maldonado R, Orozco-Covarrubias ML. Postinflamma- tory hypopigmentation and hyperpigmentation. Semin Cutan Med Surg. 1997;16:36-43.
28. Park JY, Park JH, Kim SJ, Kwon JE, Kang HY, Lee ES, et al. Two histopathological patterns of postinflammatory hyperpigmentation: epidermal and dermal. J Cutan Pathol. 2017;44(2):118 24.
29. Halder R, Munhutu M, Foltis P, Battie C, Verschoore M, Ore- sajo C. Evaluation and effectiveness of photoprotection com- position (sunscreen) on subjects of skin of color (abstract). J Am Acad Dermatol. 2015;72(5 Suppl):AB215.
30. Schneider J. The teaspoon rule of applying sunscreen. Arch Dermatol. 2002 Jun;138(6):838-9. doi: 10.1001/archderm.138.6.838-b. PMID: 12056975.
31. Marcus G. Tan, Whan B. Kim, Christine E. Jo, Karina Nabieva, Carly Kirshen & Arisa E. Ortiz (2021) Topical treatment for postinflammatory hyperpigmentation: a systematic review,Journal of Dermatological Treatment, DOI: 10.1080/09546634.2021.1981814
32. Jacyk WK, Mpofu P. Adapalene gel 0.1% for topical treatment of acne vulgaris in African patients. Cutis. 2001;68(4 suppl): 48-54
33. Kang HY, Valerio L, Bahadoran P, Ortonne JP. The role of topical retinoids in the treatment of pigmentary disorders: an evidence-based review. Am J Clin Dermatol. 2009;10(4):251-60. doi: 10.2165/00128071-200910040-00005. PMID: 19489658.
34. Kligman AM, Willis I. A new formula for depigmenting human skin. Arch Dermatol. 1975 Jan;111(1):40-8. PMID: 1119822.
35. Jimbow K, Obata H, Pathak MA, Fitzpatrick TB. Mechanism of depigmentation by hydroquinone. J Invest Dermatol. 1974 Apr;62(4):436-49. doi: 10.1111/1523-1747.ep12701679. PMID: 4206837.
36. Lowe NJ, Rizk D, Grimes P, Billips M, Pincus S. Azelaic acid 20% cream in the treatment of facial hyperpigmentation in darker-skinned patients. Clin Ther. 1998 Sep-Oct;20(5):945-59. doi: 10.1016/s0149-2918(98)80076-3. PMID: 9829446.
37. Kircik LH. Efficacy and safety of azelaic acid (AzA) gel 15% in the treatment of post-inflammatory hyperpigmentation and acne: a 16-week, baseline-controlled study. J Drugs Dermatol. 2011;10:586-590
38. Nguyen QH, Bui TP. Azelaic acid: pharmacokinetic and pharmacodynamic properties and its therapeutic role in hyperpigmentary disorders and acne. Int J Dermatol. 1995;34(2):75 84
39. Draelos ZD, Yatskayer M, Bhushan P, et al. Evaluation of a kojic acid, emblica extract, and glycolic acid formulation compared with hydroquinone 4% for skin lightening. Cutis. 2010;86:153-158.
40. Desai S, Ayres E, Bak H, Manco M, Lynch S, Raab S, Du A, Green D, Skobowiat C, Wangari-Talbot J, Zheng Q. Effect of a Tranexamic Acid, Kojic Acid, and Niacinamide Containing Serum on Facial Dyschromia: A Clinical Evaluation. J Drugs Dermatol. 2019 May 1;18(5):454-459. PMID: 31141852.
41. Lim JT. Treatment of melasma using kojic acid in a gel containing hydroquinone and glycolic acid. Dermatol Surg. 1999;25:282-284
42. Lee DH, Oh IY, Koo KT, et al. Reduction in facial hyperpig-mentation after treatment with a combination of topical niacinamide and tranexamic acid: a randomized, double-blind, vehicle-controlled trial. Skin Res Technol. 2014; 20:208-212.
43. Castanedo-Cazares JP, Larraga-Pinones G, Ehnis-Perez A, et al. Topical niacinamide 4% and desonide 0.05% for treatment of axillary hyperpigmentation: a randomized, double-blind, placebo-controlled study. Clin Cosmet Investig Dermatol. 2013;6:29-36
44. Hakozaki T, Minwalla L, Zhuang J, et al. The effect of niacinamide on reducing cutaneous pigmentation and sup- pression of melanosome transfer. Br J Dermatol. 2002;147: 20-31
45. Burns RL, Prevost-Blank PL, Lawry MA, et al. Glycolic acid peels for postinflammatory hyperpigmentation in black patients. A comparative study. Dermatol Surg. 1997;23: 171-174.
46. Grimes PE. The safety and efficacy of salicylic acid chemical peels in darker racial-ethnic groups. Dermatol Surg. 1999;25: 18-22
47. Ahn HH, Kim IH. Whitening effect of salicylic acid peels in Asian patients. Dermatol Surg. 2006 Mar;32(3):372-5; discussion 375. doi: 10.1111/j.1524-4725.2006.32075.x. PMID: 16640681.
48. O’Connor AA, Lowe PM, Shumack S, Lim AC. Chemical peels: A review of current practice. Australas J Dermatol. 2018 Aug;59(3):171-181. Doi: 10.1111/ajd.12715. Epub 2017 Oct 24. PMID: 29064096.
49. Lee KC, Wambier CG, Soon SL, Sterling JB, Landau M, Rullan P, Brody HJ; International Peeling Society. Basic chemical peeling: Superficial and medium-depth peels. J Am Acad Dermatol. 2019 Aug;81(2):313-324. Doi: 10.1016/j.jaad.2018.10.079. Epub 2018 Dec 11. PMID: 30550830.
50. И.Е. Эрнандес «Химические пилинги в практике косметолога», ИД «Косметика и Медицина», Москва 2021
51. Agbai O, Hamzavi I, Jagdeo J. Laser Treatments for Postinflammatory Hyperpigmentation: A Systematic Review. JAMA Dermatol. 2017 Feb 1;153(2):199-206. doi: 10.1001/jamadermatol.2016.4399. PMID: 27973642.
52. Dayal S, Sahu P, Sangal B, Sharma S. Role of chemical peels in postinflammatory hyperpigmentation: a comprehensive review. Pigment Int 2019;6:59-66.
53. Ho WS, Chan HH, Ying SY, Chan PC, Burd A, King WW. Prospective study on the treatment of postburn hyperpigmenta- tion by intense pulsed light. Lasers Surg Med. 2003;32(1):42 5.
54. Kim S, Cho KH. Treatment of facial postinflammatory hyper- pigmentation with facial acne in Asian patients using a Q-switched neodymium-doped yttrium aluminum garnet laser. Dermatol Surg. 2010;36(9):1374 80.
55. Cho SB, Park SJ, Kim JS, Kim MJ, Bu TS. Treatment of post- inflammatory hyperpigmentation using 1064-nm Q-switched Nd: YAG laser with low fluence: report of three cases. J Eur Acad Dermatol Venereol. 2009;23(10):1206 7.
56. Zawar VP, Agarwal M, Vasudevan B. Treatment of postin- flammatory pigmentation due to acne with Q-Switched neody- mium-doped yttrium aluminum garnet in 78 Indian cases. J Cutan Aesthet Surg. 2015;8(4):222 6.
57. Лазеры в практике косметолога и дерматолога. Принципы работы и возможности использования Эрнандес Е.И., Раханская Е.М., Шептий О.В., Калашникова Н.Г., Уракова Д.С., Дудкина С.Г. Под общ. ред. Эрнандес Е.И., Раханской Е.М. Издательский дом "Косметика & Медицина" , 2021 г. Мягкая обложка, 212 стр., илл. ISBN 978-5-901100-67-7
58. Katz TM, Goldberg LH, Firoz BF, et al. Fractional photo- thermolysis for the treatment of postinflammatory hyperpig- mentation. Dermatol Surg. 2009;35:1844-1848.
59. Gillbro JM, Olsson MJ. The melanogenesis and mechanisms of skin-lightening agents--existing and new approaches. Int J Cosmet Sci. 2011 Jun;33(3):210-21. doi: 10.1111/j.1468-2494.2010.00616.x. Epub 2011 Jan 25. PMID: 21265866.
60. Экспериментальные доказательства влияния инъекционного препарата Meso-Xanthin F199™ на меланогенез / С. Г. Морозов, Е. Н. Волкова, А. А. Григорьева [и др.] // Метаморфозы. 2017. № 17. С. 60-64.
61. MAPK and Notch-Mediated Effects of Meso-Xanthin F199 Compounds on Proliferative Activity and Apoptosis of Human Melanocytes in Three-Dimensional Culture / I. N. Saburina, I. M. Zurina, N. V. Kosheleva [et al.] // BioMed Research International. 2021. Vol. 2021. P. 8463161. DOI 10.1155/2021/8463161.
62. Konda D, Thappa DM. Mesotherapy: What is new? Indian J Dermatol Venereol Leprol. 2013 Jan-Feb;79(1):127-34. doi: 10.4103/0378-6323.104689. PMID: 23254749.
63. Kandhari R, Kaur I, Sharma D. Mesococktails and mesoproducts in aesthetic dermatology. Dermatol Ther. 2020 Nov;33(6):e14218. doi: 10.1111/dth.14218. Epub 2020 Sep 10. PMID: 32827194.
64. Rostan EF, DeBuys HV, Madey DL, Pinnell SR. Evidence supporting zinc as an important antioxidant for skin. Int J Dermatol. 2002 Sep;41(9):606-11. doi: 10.1046/j.1365-4362.2002.01567.x. PMID: 12358835.
65. Yousefi A, Khani Khoozani Z, Zakerzadeh Forooshani S, Omrani N, Moini AM, Eskandari Y. Is topical zinc effective in the treatment of melasma? A double-blind randomized comparative study. Dermatol Surg. 2014 Jan;40(1):33-7. doi: 10.1111/dsu.12296. Epub 2013 Nov 14. PMID: 24237751.
66. Lansdown AB, Mirastschijski U, Stubbs N, Scanlon E, Agren MS. Zinc in wound healing: theoretical, experimental, and clinical aspects. Wound Repair Regen. 2007 Jan-Feb;15(1):2-16. doi: 10.1111/j.1524-475X.2006.00179.x. PMID: 17244314.
67. Sarkar R, Arora P, Garg KV. Cosmeceuticals for Hyperpigmentation: What is Available? J Cutan Aesthet Surg. 2013 Jan;6(1):4-11. doi: 10.4103/0974-2077.110089. PMID: 23723597; PMCID: PMC3663177.
68. Maeda K, Fukuda M. Arbutin: mechanism of its depigmenting action in human melanocyte culture. J Pharmacol Exp Ther. 1996 Feb;276(2):765-9. PMID: 8632348.
69. Boissy RE, Visscher M, DeLong MA. DeoxyArbutin: a novel reversible tyrosinase inhibitor with effective in vivo skin lightening potency. Exp Dermatol. 2005 Aug;14(8):601-8. doi: 10.1111/j.0906-6705.2005.00337.x. PMID: 16026582.
70. Saeedi M, Khezri K, Seyed Zakaryaei A, Mohammadamini H. A comprehensive review of the therapeutic potential of α-arbutin. Phytother Res. 2021 Aug;35(8):4136-4154. doi: 10.1002/ptr.7076. Epub 2021 Mar 16. PMID: 33724594.
71. Вавилова, А. А. Сравнительное исследование двух схем применения ретиноевого пилинга у женщин с фотостарением лица / А. А. Вавилова, Е. И. Губанова, Г. Ш. Закирова // Вестник последипломного медицинского образования. 2019. № 1. С. 88-94.
72. Касихина Е. И. Гиперпигментация //Медицинский научно-практический журнал № 6 2011. 2010. С.
73. Choi SY, Yoo KH, Oh CT, Kwon TR, Choi EJ, Seok J, Kim BJ. High intensity focused ultrasound as a potential new modality for the treatment of pigmentary skin disorder. Skin Res Technol. 2016 May;22(2):131-6. doi: 10.1111/srt.12239. Epub 2015 Jun 19. PMID: 26094501.
74. Hakozaki T, Takiwaki H, Miyamoto K, Sato Y, Arase S. Ultrasound enhanced skin-lightening effect of vitamin C and niacinamide. Skin Res Technol. 2006 May;12(2):105-13. doi: 10.1111/j.0909-752X.2006.00186.x. PMID: 16626384.
75. Vachiramon V, Iamsumang W, Chanasumon N, Thadanipon K, Triyangkulsri K. A study of efficacy and safety of high-intensity focused ultrasound for the treatment of melasma in Asians: A single-blinded, randomized, split-face, pilot study. J Cosmet Dermatol. 2020 Feb;19(2):375-381. doi: 10.1111/jocd.13044. Epub 2019 Jun 7. PMID: 31173464.
76. Maisel-Campbell AL, Ismail A, Reynolds KA, Poon E, Serrano L, Grushchak S, Farid C, West DP, Alam M. A systematic review of the safety and effectiveness of platelet-rich plasma (PRP) for skin aging. Arch Dermatol Res. 2020 Jul;312(5):301-315. doi: 10.1007/s00403-019-01999-6. Epub 2019 Oct 18. PMID: 31628542.
77. Merchán WH, Gómez LA, Chasoy ME, Alfonso-Rodríguez CA, Muñoz AL. Platelet-rich plasma, a powerful tool in dermatology. J Tissue Eng Regen Med. 2019 May;13(5):892-901. doi: 10.1002/term.2832. Epub 2019 Apr 9. PMID: 30793521.
78. Sirithanabadeekul P, Dannarongchai A, Suwanchinda A. Platelet-rich plasma treatment for melasma: A pilot study. J Cosmet Dermatol. 2020 Jun;19(6):1321-1327. doi: 10.1111/jocd.13157. Epub 2019 Sep 30. PMID: 31568636.
79. Hofny ERM, Abdel-Motaleb AA, Ghazally A, Ahmed AM, Hussein MRA. Platelet-rich plasma is a useful therapeutic option in melasma. J Dermatolog Treat. 2019 Jun;30(4):396-401. doi: 10.1080/09546634.2018.1524821. Epub 2018 Nov 29. PMID: 30220226.
80. Mumtaz M, Chandio TH, Shahzad MK, Hanif N, Anwar S, Rafique S. Comparing the Efficacy of Patelet-rich Plasma (PRP) versus Tranexamic Acid (4mg/mL) as Intradermal Treatments of Melasma. J Coll Physicians Surg Pak. 2021 May;30(5):502-505. doi: 10.29271/jcpsp.2021.05.502. PMID: 34027858.
81. Tuknayat A, Thami GP, Bhalla M, Sandhu JK. Autologous intralesional platelet rich plasma improves melasma. Dermatol Ther. 2021 Mar;34(2):e14881. doi: 10.1111/dth.14881. Epub 2021 Feb 28. PMID: 33591615.